MX2017011028A - Combinacion de un retinoide y un diol y ester de acido graso poliinsaturado. - Google Patents

Combinacion de un retinoide y un diol y ester de acido graso poliinsaturado.

Info

Publication number
MX2017011028A
MX2017011028A MX2017011028A MX2017011028A MX2017011028A MX 2017011028 A MX2017011028 A MX 2017011028A MX 2017011028 A MX2017011028 A MX 2017011028A MX 2017011028 A MX2017011028 A MX 2017011028A MX 2017011028 A MX2017011028 A MX 2017011028A
Authority
MX
Mexico
Prior art keywords
combination
retinoid
diol
fatty acid
acid ester
Prior art date
Application number
MX2017011028A
Other languages
English (en)
Inventor
Redoules Daniel
Castex-Rizzi Nathalie
Hilaire Saurat Jean-
BESSOU-TOUYA Sandrine
Original Assignee
Pierre Fabre Dermo-Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Dermo-Cosmetique filed Critical Pierre Fabre Dermo-Cosmetique
Publication of MX2017011028A publication Critical patent/MX2017011028A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención se refiere a una combinación de un retinoide y un diol y éster de ácidos grasos poliinsaturados, a una composición dermatológica o dermocosmética que contiene tal combinación y el uso de la misma en el tratamiento contra el acné y para prevenir lesiones retencionales. La presente invención también se refiere a un retinoide, opcionalmente combinado con un diol y un éster de ácidos grasos poliinsaturados, para su uso en la prevención de lesiones retencionales.
MX2017011028A 2015-02-27 2016-02-29 Combinacion de un retinoide y un diol y ester de acido graso poliinsaturado. MX2017011028A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1551714A FR3033135B1 (fr) 2015-02-27 2015-02-27 Association d'un retinoide et d'un ester de diol et d'acide gras polyinsature
PCT/EP2016/054227 WO2016135340A1 (en) 2015-02-27 2016-02-29 Combination of a retinoid and a diol and polyunsaturated fatty acid ester

Publications (1)

Publication Number Publication Date
MX2017011028A true MX2017011028A (es) 2017-11-10

Family

ID=53200134

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017011028A MX2017011028A (es) 2015-02-27 2016-02-29 Combinacion de un retinoide y un diol y ester de acido graso poliinsaturado.

Country Status (15)

Country Link
US (1) US10188625B2 (es)
EP (1) EP3261719B1 (es)
KR (1) KR20170122764A (es)
AR (1) AR103781A1 (es)
BR (1) BR112017017162A2 (es)
CA (1) CA2976605A1 (es)
ES (1) ES2839877T3 (es)
FR (1) FR3033135B1 (es)
MX (1) MX2017011028A (es)
PT (1) PT3261719T (es)
RU (1) RU2704109C2 (es)
TN (1) TN2017000363A1 (es)
TW (1) TW201639549A (es)
WO (1) WO2016135340A1 (es)
ZA (1) ZA201705670B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019068288A1 (de) 2017-10-04 2019-04-11 Berlimed International Research Gmbh Wirkstoff und wirkstoffmatrix enthaltendes produkt zur transdermalen wirkstoffabgabe sowie dessen herstellung und verwendung sowie die wirkstoffmatrix, ihre herstellung und verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885595A (en) * 1996-05-13 1999-03-23 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic composition with a retinol fatty acid ester
US6521237B2 (en) * 1998-11-12 2003-02-18 Johnson & Johnson Consumer Companies, Inc. Skin care composition
US20080139518A1 (en) * 2006-12-04 2008-06-12 Concert, Llc Topical compositions for treatment of skin conditions
FR2940281B1 (fr) * 2008-12-22 2011-04-01 Fabre Pierre Dermo Cosmetique Ester de diol et d'acide gras polyinsature comme agent anti-acne
FR2940907B1 (fr) * 2009-01-15 2011-03-04 Oreal Composition cosmetique ou dermatologique, comprenant un retinoide, un compose non phosphate a base d'adenosine et un polymere semi-cristallin

Also Published As

Publication number Publication date
RU2017131342A (ru) 2019-03-28
AR103781A1 (es) 2017-05-31
EP3261719A1 (en) 2018-01-03
TW201639549A (zh) 2016-11-16
PT3261719T (pt) 2021-01-05
FR3033135B1 (fr) 2018-03-16
US10188625B2 (en) 2019-01-29
WO2016135340A1 (en) 2016-09-01
RU2017131342A3 (es) 2019-05-17
RU2704109C2 (ru) 2019-10-24
ES2839877T3 (es) 2021-07-06
EP3261719B1 (en) 2020-09-30
CA2976605A1 (en) 2016-09-01
BR112017017162A2 (pt) 2018-04-03
TN2017000363A1 (en) 2019-01-16
US20180036275A1 (en) 2018-02-08
FR3033135A1 (fr) 2016-09-02
KR20170122764A (ko) 2017-11-06
ZA201705670B (en) 2019-03-27

Similar Documents

Publication Publication Date Title
PH12021550756A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
SG10201907660YA (en) Use of short chain fatty acids in cancer prevention
PH12018500029A1 (en) Microbiome-compatible cosmetics
MX2016016761A (es) Metodo para el tratamiento del cabello con un acondicionador concentrado.
MX2022007816A (es) Compuestos eficaces en el tratamiento de la hepatotoxicidad y enfermedades de higado graso, y uso de los mismos.
WO2014111811A8 (en) Veterinary supplements
EP3296308A4 (en) Dextrin fatty acid ester and cosmetic
MX2016014396A (es) Preparacion de enjuague bucal mejorada.
EP3310366A4 (en) Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne
PH12017502403A1 (en) Musk composition and methods of use thereof
MX2018006868A (es) Composicion con sabor y olor estabilizado.
IL276596A (en) Polyunsaturated fatty acids, monoglycerides, compounds, methods and use thereof
ZA201702385B (en) Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
MX353580B (es) Acido graso monoinsaturado para prevenir y/o tratar las imperfecciones del color de la piel.
PH12016502311A1 (en) Omega-3 analogues
PL3346980T3 (pl) Lipofilowe kompozycje kosmetyczne zawierające estry kwasu pelargonowego
EP3345986A4 (en) COMPOSITION COMPRISING FREE POLYUNSATURATED FATTY ACID, AND PROCESS FOR PRODUCTION THEREOF
GEAP202014717A (en) Selected amide of γ-hydroxybutyric acid and uses thereof in the treatment of alcohol misuse
MX355668B (es) Uso de un extracto de mirto como un agente anti-biopelicula contra propionibacterium acnes.
MX2021001790A (es) Composiciones solidas de trigliceridos y usos de estas.
MX370990B (es) Ésteres de ácidos oligo-hidroxicarboxílicos y uso de los mismos.
TN2017000363A1 (en) Combination of a retinoid and a diol and polyunsaturated fatty acid ester
EP3787614A4 (en) MULTIPLE UNSATURATED FATTY ACID MONOGLYCERIDES, COMPOSITIONS, PROCESSES AND USES THEREOF
BR112016028561A8 (pt) composição e forma de dosagem compreendendo um óleo marinho que compreende ácidos graxos, e, uso das mesmas
WO2015044317A3 (en) Staphylococcus haemolyticus inhibitors for preventing and/or treating atopic dermatitis